OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and thank you for joining OptumRx's third quarter fiscal year 2025 earnings conference call. With us today is Chief Executive Officer Steve Silvestro. He is joined by Chief Financial and Strategic Officer Ed Stilmach, Chief Legal and Administrative Officer Marion Odense-Ford, and Chief Business Officer Andrew DaSilva. At the conclusion of today's call, I will provide some important cautions regarding forward-looking statements made by management during today's call. The company will also be discussing certain non-GAAP financial measures, which it believes are useful in evaluating the company's operating results. A reconciliation of such non-GAAP financial measures is included in the earnings released the company issued this afternoon, as well as in the investor relations section of the company's website. I would like to remind everyone that today's call is being recorded and will be made available for replay on audio recording of the conference call on the investor relations section of the company's website. Now I would like to turn the call over to OptimRx's CEO, Steve Silvestro. Mr. Silvestro, please go ahead. Thank you, Operator, and good afternoon to everyone joining our third quarter 2025 earnings call. We had a strong third quarter with results ahead of both consensus estimates and our internal expectations. Our Q3 revenues increased 22% year-over-year to $26.1 million, and our adjusted EBITDA was $5.1 million, an improvement of over $2 million from the same period last year. Our contracted revenue remains well ahead of last year's pace, underscoring the success of our focus on operational excellence, our dedication to delighting customers and deepening relationships with trusted partners. Before we move on, I want to take a moment to ...